Treatment ethics, quality of life and health economics in the management of hematopoietic malignancies in older patients
G-CSF-primed bone marrow as a source of stem cells for allografting: revisiting the concept
Pushing the envelope—nonmyeloablative and reduced intensity preparative regimens for allogeneic hematopoietic transplantation
Recommendations on hematopoietic stem cell transplantation for inherited bone marrow failure syndromes
Risk factors and timing of relapse after allogeneic transplantation in pediatric ALL: for whom and when should interventions be tested?
Outcomes of patients with therapy-related AML/myelodysplastic syndrome (t-AML/MDS) following hematopoietic cell transplantation
Integration of humoral and cellular HLA-specific immune responses in cord blood allograft rejection
Preserved in vivo reconstitution ability of PBSCs cryopreserved for a decade at -80 °C
High-resolution HLA matching in unrelated donor transplantation in Switzerland: differential impact of class I and class II mismatches may reflect selection of nonimmunogenic or weakly immunogenic DRB1/DQB1 disparities
Ovarian tissue cryopreservation in girls undergoing haematopoietic stem cell transplant: experience of a single centre
Arrhythmias in the setting of hematopoietic cell transplants
Increased incidence of chronic GvHD and CMV disease in patients with vitamin D deficiency before allogeneic stem cell transplantation
A cross-sectional study on vision-related quality of life in patients with ocular GvHD
Quantitative characterization of T-cell repertoire in allogeneic hematopoietic stem cell transplant recipients
Prognostic significance of pre-transplant quality of life in allogeneic hematopoietic cell transplantation recipients
Patient-reported quality of life after allogeneic hematopoietic cell transplantation or chemotherapy for acute leukemia
Imatinib for bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation
IV pentamidine for primary PJP prophylaxis in adults undergoing allogeneic hematopoietic progenitor cell transplant
Cord blood unit factors influencing transplant outcomes from the Asian multiethnic Singapore Cord Blood Bank
Financial burden after allogeneic hematopoietic cell transplantation: a qualitative analysis from the patient's perspective
Early recovery of CMV immunity after HLA-haploidentical hematopoietic stem cell transplantation as a surrogate biomarker for a reduced risk of severe infections overall
Extensive bone marrow necrosis resolved by allogeneic umbilical cord blood mesenchymal stem cell transplantation in a chronic myeloid leukemia patient